Posted on

This Isn’t COVID’s Final Act

Loading

— We must keep the virus, and long COVID, center stage

by Stuart Katz, MD, Alice Perlowski, MD, MA, and Brittany Taylor, MPH 

This year marks the third year of the COVID-19 pandemic. Over time, as the virus morphed and continued to disrupt our daily lives, people around the world grew tired of COVID restrictions. As a result, we saw mask mandates lift, social distancing practices fade, and vaccination rates decline as more shots became available. Understandably, people were — and still are — longing for pre-pandemic normalcy.
Read the full article in MedPage Today.

Loading
Posted on

Inflammation a Culprit in Long COVID Heart Problems

Loading

— Prospective study illuminates mechanisms of lingering heart issues after mild COVID-19

While long COVID holds many mysteries, researchers found clues to the heart symptoms common in these patients, which pointed to ongoing inflammation as the mediator.

In a cohort of 346 previously healthy patients with initially mild COVID-19, most seen for lingering symptoms a median of around 4 months later, structural heart disease and elevated biomarkers for cardiac injury or dysfunction were rare. Read the full story in MedPage Today.

Loading
Posted on

Insights on Long COVID Care

Loading

— Fernando Carnavali, MD, discusses helping patients adjust to being chronically ill

In this video, Fernando Carnavali, MD, of Mount Sinai’s Center for Post-COVID Care in New York City, discusses the strategies for managing long COVID and what we still don’t know about this often debilitating condition.

The following is a transcript of his remarks:

The population of post-COVID, long COVID, has changed over time. I think that one of the most significant changes is that the population is more aware of these chronic conditions, and I think that the uncertainties are still there.
Watch the video and read the transcript on MedPage Today here.

Loading
Posted on

Is Diabetes a Risk Factor for Long COVID? Possibly.

Loading

— Mixed results in seven-study scoping review

The jury is still out as to whether diabetes is a risk factor for post-acute sequelae of COVID-19 (PASC), a researcher reported.

In a scoping review of seven studies, three (43%) concluded that diabetes was indeed a “potent” risk factor for developing long COVID following infection, according to Jessica L. Harding, PhD, of Emory University School of Medicine in Atlanta.
Read more in MedPage Today.

Loading